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Background and Purpose—Considerable clinical and radiological overlap between vascular dementia (VaD) and
Alzheimer disease (AD) often makes the diagnosis difficult. Diffusion-tensor imaging studies showed that fractional
anisotropy (FA) could be a useful marker for white matter changes. This study aimed to identify regional FA changes
to identify a biomarker that could be used to differentiate VaD from AD.
Methods—T1-weighted and diffusion-tensor imaging scans were obtained in 13 VaD patients, 16 AD patients, and 22
healthy elderly controls. We used tract-based spatial statistics to study regional changes in fractional anisotropy in AD,
VaD, and elderly controls. We then used probabilistic tractography to parcel the corpus callosum in 7 regions according
to its connectivity with major cerebral cortices using diffusion-tensor imaging data set. We compared the volume and
mean FA in each set of transcallosal fibers between groups using ANOVA and then applied a discriminant analysis
based on FA and T2-weighted imaging measures.
Results—FA reduction in forceps minor was the most significant area of difference between AD and VaD. Segmentation
of the corpus callosum using tractography and comparison of FA changes of each segment confirmed the FA changes
in transcallosal prefrontal tracts of patients with VaD when compared to AD. The best discriminant model was the
combination of transcallosal prefrontal FA and Fazekas score with 87.5% accuracy, 100% specificity, and 93%
sensitivity (P0.0001).
Conclusion—Integrating mean FA in the forceps minor to the Fazekas score provides a useful quantitative marker for
differentiating AD from VaD. (Stroke. 2009;40:773-779.)
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Differentiating vascular dementia (VaD) from Alzheimerdisease (AD) can be difficult. Vascular disease of the
brain is a common cause of cognitive impairment that may
lead to VaD.1 The clinical diagnosis of VaD made using
established criteria are not optimally specific and are insen-
sitive.2 The neuropsychological profile of patients with VaD
generally shows more impairment in semantic memory,
executive/attentional functioning, and visual-spatial and per-
ceptual skills, whereas the clinical picture of AD is charac-
terized by deficits in episodic memory.3 However, a recent
study on neuropathologically confirmed cases of VaD and
AD showed that the neuropsychological profile is a rather
poor discriminator.4
There are studies such as MRC-FAS,5 NUN,6 Lille,7 and
ours8 that indicate that VaD overlaps with AD, although pure
forms, such as in CADASIL, certainly exist.9,10 In addition,
white matter lesions seen on MRI do not correlate well with
cognitive impairment in VaD11 and cannot differentiate VaD
from histologically confirmed AD.12 Clearly, from a thera-
peutic standpoint, identifying the exact pathological compo-
nents contributing to the dementia syndrome at the very early
stages is important to guide therapy. Advances in neuroim-
aging techniques provide new tools to address this problem.
Diffusion-tensor imaging is a noninvasive method for
visualization of white matter pathways in the human brain in
vivo. Fractional anisotropy has been used extensively as a
marker for white matter integrity, including in AD13 and
VaD.14 However, no specific discriminator between AD and
VaD has been identified. In this study, we used sophisticated
image processing algorithms to identify the regional pattern
of fractional anisotropy (FA) changes in VaD compared to
AD and elderly controls (EC).
Subjects and Methods
Subjects
All data were obtained at the Alzheimer Center of the VU University
Medical Center, Amsterdam, Netherlands. The cohort included VaD
patients (n13), AD patients (n16), and healthy EC (n22).
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Patients were carefully selected on the basis of clinical records and
MRI findings after clinical diagnosis by a cognitive neurologist
(P.S.) during 2004 to 2006. VaD patients were selected among those
who received diagnosis of VaD. Only VaD patients who fully met
the diagnostic criteria of VaD based on the NINDS-AIREN criteria15
and the radiological NINDS-AIREN criteria16 were invited to
participate in this study. This selection procedure was necessary to
ensure purity of the VaD group. Diagnostic criteria for AD con-
formed to those of NINCDS-ADRDA,16a with Mini-Mental State
Examination scores 18 and Clinical Dementia Ratings 2. These
values correspond to what is known as mild AD. The Medical Ethics
Committee of the VU University Medical Center Amsterdam ap-
proved the study. All subjects provided informed consent; patients
were under supervision of their legal guardian if necessary. Partici-
pants were excluded if they had any significant neurological (except
for the diseases undergoing study here in the patient groups and
commonly found general medical conditions in the elderly, such as
ischemic heart disease and hypertension) or psychiatric illnesses; a
history of brain damage; or if they were using medication known to
influence cerebral function (except for disease-related medication in
the patient groups). T2-weighted fluid attenuation inversion recovery
scans of each subject were reviewed by a neuroradiologist to assess
the presence of vascular lesions.
MRI Acquisition
MRI examinations were conducted on a 1.5-T Sonata system
(Sonata; Siemens AG) and included a T1-weighted 3-dimensional
gradient sequence (repetition time2700 ms; echo time3.97 ms;
flip angle8°; 160 coronal slices; voxel size: 11.51 mm).
Diffusion-tensor imaging was measured using an echo planar imag-
ing sequence with the following specifications: repetition
time8500 ms; echo time86 ms; voxel size, 2 mm isotropic; 59
consecutive slices; acquisition matrix 128 mm128 mm (field of
view256 mm); 6/8 partial Fourier; 60 diffusion directions with b
value700 s/mm2; and 10 images with no diffusion weighting (b0
s/mm2). The bandwidth was 1860 Hz/pixel.
Image Analysis
Image analyses were performed using tools from FSL (FMRIB
Software Library, http://www.fmrib.ox.ac.uk/fsl).17 Brain Extraction
Tool was used for brain extraction of T1-weighted images.18
FMRIB’s Linear Image Registration Tool was used to derive
affine transformation matrices between diffusion and T1-weighted
images.19 Effects of eddy currents and head motion were reduced by
registering all diffusion-weighted images to a nondiffusion-weighted
reference image using fully affine 12-degrees-of-freedom registra-
tion. Analyses of diffusion images were performed using tools from
FMRIB’s Diffusion Tool (FMRIB Diffusion Toolkit). Probabilistic
modeling of diffusion parameters and tractography were performed
using previously described methods.20
Voxel-Wise FA Analysis
Statistical analysis of the FA data were performed using tract-based
spatial statistics, which has been described elsewhere in detail.17
Briefly, FA images were created by fitting the diffusion-tensor to the
raw diffusion data and then brain-extracted.18 The next analysis steps
were performed separately for the EC, VaD, and AD groups. All
subjects’ FA data were aligned into a common space using the
nonlinear registration as implemented in Image Registration Tool
Kit.21 Next, the mean FA image was created and thinned to create a
mean FA skeleton, which represents the centers of all tracts common
to all groups. Each subject’s aligned FA data were then projected
onto this skeleton and the resulting data were fed into cross-subject
statistics. Group differences in global FA integrity were calculated
by comparing mean FA values within the skeleton mask (thresholded
at a mean FA value of 0.2). Nonparametric 2-sample Mann-Whitney
U tests were used to test for significant differences between groups.
Voxel-wise statistics were performed using a permutation-based
inference tool for nonparametric statistical thresholding (“Random-
ize” tool, part of FMRIB’s Software Library).22 All voxel-wise group
comparisons were performed using simple 2-sample t tests on group
mean FA skeleton (thresholded at a mean FA value of 0.25) and the
number of permutation tests was set to 5000.
Transcallosal Tractography
Probabilistic tractography between the corpus callosum and 7 major
cerebral cortical regions performed using FDT (FMRIB Diffusion
Toolkit)20 was performed on the diffusion data. Each subject’s brain
was first aligned with the Montreal Neurological Institute brain using
a 6-degrees-of-freedom transformation (ie, without changing the
brain volume). Tissue-type segmentation18 then was performed and
a midsagittal section of the corpus callosum (CC) (seed mask) was
obtained from the estimated white matter. Cortical masks (target
masks) included prefrontal cortical (PFC) region, premotor cortical
region, M1, S1, posterior parietal cortical region, temporal cortical
region, and occipital cortical region of each hemisphere and were
obtained from probabilistic maps of cortical regions (Harvard-
Oxford Cortical Structural Atlas, part of FMRIB’s Software Library
Viewer). Only voxels present in at least 70% of subjects were
retained. Cortical masks were then registered to the T1-weighted
images of each subject and masked with the gray matter maps
obtained by tissue-type segmentation.18 The resulting images were
binarized and used as the target mask for tractography.
For each individual, the tractography algorithm was run between
every voxel inside the CC and each cortical mask. The voxels within
the CC were classified according to their connectivity with the
cortical targets. Such connectivity-based classification was per-
formed separately for each hemisphere (using the same CC seed
mask) and the result was averaged for each region between hemi-
spheres. The resulting regions often overlap.23 To eliminate this
potential problem, probability of connectivity of each voxel was
normalized and hard segmentation was performed to find the most
probable border between adjacent regions.23
Volume measurements of white matter, gray matter, and CC
regions were normalized for differences in total intracranial volume
among subjects by means of an analysis of covariance approach,
which adjusts observed volumes by an amount proportional to the
difference between an individual’s observed intracranial volume and
the mean intracranial volume for all subjects.24 This approach results
in a more Gaussian distribution than does the usual “ratio adjust-
ment” approach, in which an individual brain volume is divided by
total cranial volume,25 which tends to yield positively skewed
values.24
Statistical Analyses
Subsequent to volume correction, we calculated the region and mean
FA for each CC region. In addition, volumes of the total brain tissue,
gray matter, and white matter were also calculated. Univariate
ANOVA, with Bonferroni post hoc comparisons, were used for
investigating differences in volume and FA values of each CC region
across the groups. The level of statistical significance was set at
0.01. To assess more precisely the differences of all measures
between AD and VaD patients, effect sizes (d) of these measures
were determined.26 Measures that showed large effect sizes (d0.8)
were used in discriminant analysis with leave-one-out cross-
validation test with a stepwise approach (criterion for removal was
set to P0.10).
Results
Demographic and Neuropsychological Data
Table 1 shows demographic data of our subjects. There were
no differences across groups with respect to age, education,
intelligence quotient, alcohol intake, and number of cigarettes
smoked. There was a strong difference between the Mini-
Mental State Examination and Clinical Dementia Ratings
scores of patients compared with EC (P0.0001), but no
difference was seen between AD and VaD patients, demon-
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strating that these 2 groups were not distinguishable on the
basis of these scores only.
Across the AD and control groups, white matter abnormal-
ities were observed in 25 out of 40 subjects. These consisted
of punctiform white matter lesions in x, early confluent
lesions in y, and confluent white matter lesions in z sub-
jects.27 Between-group comparison of Fazekas score showed
significant (P0.0001) effect of the groups that was attrib-
uted to difference between AD and VaD (Table 1).
Quantitative Volumetry
There were significant differences across groups in total brain
tissue, gray matter, and white matter volumes (Table 2). Post
hoc comparisons showed that in VaD patients the total brain
tissue, white matter, and gray matter volumes were signifi-
cantly reduced compared with EC, but not compared with
AD. The volume of gray matter was also significantly
reduced in AD patients compared with EC, whereas total
brain tissue and white matter volume were not significantly
different between these 2 groups.
Total CC volume was not significantly different across
groups. Analyses of CC regions showed no difference in total
CC volume across groups but significant reduction of tran-
scallosal PFC volume in VaD when compared with EC. No
significant difference was found between AD and EC in the
volume of CC regions.
FA Analysis
Mean FA values of the white matter in each group are shown
in Table 3. White matter FA value in the VaD was signifi-
cantly less than in EC; however, only a trend was observed
when VaD was compared with AD. There was no significant
difference between mean white matter FA of EC and AD. A
similar pattern of difference was seen in the FA value of CC
across the groups. CCFA in VaD was significantly less than
in EC, but showed no difference when compared with AD.
Tract-based spatial statistics analysis showed that the
pattern of FA changes in VaD was clearly different from AD.
Contrasting EC and AD showed reduced FA mainly in the
medial temporal white matter and uncinate fasciculus (Fig-
ure). However, VaD patients showed FA reduction more
extensively in periventricular area, corona radiata, forceps
minor, frontal white matter, and inferior fronto-occipital
fasciculi (Figure). Contrasting AD with VaD showed FA
Table 1. Summary of Group Demographic Characteristics (MeanSD)
Characteristics EC (N22) AD (N16) VaD (N13) Group Effect F(2,48) (P)
Age 70.76.0 69.56.7 74.37.0 2.12 (0.13)
Sex, female:male 13:9 9:7 4:10
Education, yr 14.73.2 14.43.1 13.34.7 0.41 (0.67)
IQ (NARD) 110.718.7 102.519.7 99.717.3 1.40 (0.27)
CDR 0.00.0 0.810.44 1.150.52 21.8 (0.0001)
Fazekas score 0.00.0 0.880.88 2.850.38 27.7 (0.0001)
MMSE 28.71.4 22.93.2 22.13.3 28.8 (0.0001)
Alcohol use per wk 9.18.8 0.311.1 8.88.6 0.03 (0.97)
Cigarettes per wk 9.121.2 0.00.0 17.144.3 1.7 (0.19)
CDR indicates Clinical Dementia Ratings; MMSE, Mini-Mental State Examination; NARD, National Adult Reading Test.
Table 2. Comparison of TBVotal Brain Volume, Gray Matter Volume, White Matter Volume,
and CC Regions Using ANOVA With Bonferroni Correction
EC AD VaD ANOVA§ Post hoc
TBV (cm3) 1072127 99490 91294 F9, P0.0001 VaD-EC, P0.0001
GM (cm3) 65220 59125 58424 F50.3, P0.0001
VaD-EC, P0.0001
AD-EC, P0.0001
WM (cm3) 42120 41623 3989 F6.5, P0.003 VaD-EC, P0.003
CC Regions
PFC 43061 39546 35650 F7.7, P0.001 VaD-EC, P0.001
PMC 11418 10616 10122 F2.3, P0.11
PPC 17546 18031 18541 F0.27, P0.76
Temp 8226 10635 9437 F2.7, P0.08
Occ 5515 6117 5316 F1.1, P0.35
S1 3510 2915 266 F2.7, P0.08
M1 2812 268 2913 F0.21, P0.81
Total CC 92085 90660 84780 F3.9, P0.03 VaD-EC, P0.03
Gender and age were taken as covariants. Note that the CC regions are 1 voxel thick in sagittal plain.
Occ indicate occipital; GM, grey matter, PMC, premotor cortical region; PPC, posterior parietal cortical region;
Temp, temporal; WM, white matter.
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changes mainly in the forceps minor, superior and inferior
longitudinal fasciculus, as well as in the anterior and inferior
fronto-occipital fasciculus (Figure and Table 4). Details of
regional FA changes in AD in comparison with young and
old healthy volunteers have been reported elsewhere.28
Regional analysis of mean FA values of CC regions
showed significant group differences in all CC regions,
except those regions predominantly containing occipital and
temporal fibers (Table 3). Posthoc comparisons showed that
PFC FA was significantly reduced in VaD patients compared
with EC and AD patients. Premotor cortical region, parietal
cortical region, M1, and S1 showed significantly reduced FA
in VaD patients compared with EC, but not compared with
AD patient. There was no difference in FA between AD
patients and EC for any of these regions. Adding the Fazekas
score as covariant in the group comparison analysis showed
no difference in the result of this group analysis. In addition,
linear regression model between FA values and Fazekas score
showed no correlation.
Discrimination of VaD From AD
We compared effect size of each variable. Volume of PFC
region, and total CC, mean FA values of the PFC, premotor
cortical region, and temporal regions, as well as Fazekas
score, showed a significant effect size of 0.8. When each of
these areas was entered as an independent variable in single
discriminant analysis, they each showed discriminatory
power (P0.05). However, in a combined discriminant
analysis model, PFC region and Fazekas score together (with
age and sex covariants) provided the most accurate discrim-
inate between AD and VaD patients (specificity100%;
sensitivity87.5%; overall accuracy93%; 233.87; de-
grees of freedom2; P0.0001).
Discussion
This study aimed to use diffusion data for differentiating VaD
from AD. We first looked for voxel-wise FA changes of the
entire brain that showed the most significant change in the
forceps minor. We then examined transcallosal regions that
confirmed that the most significant change occurs in the
transcallosal prefrontal tracts. We found that this marker
together with Fazekas score provides sensitive and specific
markers for differentiating AD from VaD.
To our best knowledge, this is the first report in which
changes in specific tracts are identified as an accurate
biomarker for differentiation VaD from AD. This is important
because previous studies showed that ischemic white matter
lesions seen on fluid attenuation inversion recovery images
do not necessarily correlate with dementia.29 Our study in
association with that of others9 suggests that location of the
ischemic damage is crucial for the development of dementia
in VaD. In addition, Fazekas score as covariant in group
analysis had no significant effect on the result of the analysis,
suggesting that the brain damage in vascular dementia is
likely to be attributable to white matter damage that is beyond
detection by visual inspection. This highlights the importance
of quantification using diffusion-tensor imaging data.
Quantifying Diffusion-Tensor Imaging
We used fractional anisotropy as a surrogate marker for white
matter integrity. Fractional anisotropy changes has been
associated with inflammatory or degenerative damage to the
nerves.30,31 In our study, tract-based spatial statistics showed
that forceps minor, corona radiata, and fronto-occipital tracts
were particularly compromised in VaD subjects when com-
Table 3. Comparison of Mean FA Value of each CC Region Using ANOVA F(2,48) With
Bonferroni Correction
Region EC (N22) AD (N16) VaD (N13) ANOVA Post hoc
Total CC 0.460.05 0.440.05 0.400.04 F4.9, P0.01 P0.01 (VaD-EC)
PFC 0.540.05 0.520.04 0.450.04 F15.4, P0.0001
P0.0001 (VaD-EC)
P0.0001 (VaD-AD)
PMC 0.540.06 0.510.06 0.460.06 F7.9, P0.001 P0.001 (VaD-EC)
PPC 0.610.05 0.580.07 0.530.08 F5.8, P0.006 P0.004 (VaD-EC)
Temp 0.640.06 0.640.07 0.580.07 F3.8, P0.03 NS
Occ 0.620.08 0.640.09 0.580.07 F1.8, P0.17 NS
S1 0.540.08 0.480.08 0.440.08 F7.8, P0.001 P0.01 (VaD-EC)
M1 0.510.08 0.480.07 0.430.08 F4.7, P0.014 P0.009 (VaD-EC)
Gender and age were taken as covariants. Only significant results are shown.
Comparison of FA values (meanSD).
NS indicates not significant.
Table 4. Cluster Size and Coordinates of Local Maxima in
Major White Matter Tracts When FA Map in AD Was Compared
to FA Map in VaD Group Using TBSS
Size X Y Z T
Forceps minor 119 98 151 86 4.41
Right superior longitudinal
fasciculus
278 70 93 110 4.17
Left superior longitudinal
fasciculus
250 126 105 99 4.04
Left inferior fronto-occipital
fasciculus
468 123 61 78 4.10
Left anterior thalamic
radiation
107 113 160 67 4.07
The most significant clusters are within forceps minor. In addition, signifi-
cant clusters are found in other major white matter connected to prefrontal
cortex.
Cluster size and coordinates of local maxima in major white matter tracts
when AD was compared to VaD group.
TBSS indicates tract-based spatial statistics.
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pared with AD or EC. This is most likely attributable to
ischemia-induced pathology in the periventricular area, and
frontal and parietal white matter in VaD. This finding guided
us to find the corpus callosal region of interest that shows
maximum changes across subjects.
Further examination of changes in the CC using segmen-
tation of the transcallosal tracts based on diffusion-tensor
imaging tractography showed FA reduction in prefrontal and
sensorimotor interhemispheric tracts in VaD (but not in AD)
compared with EC. This suggests loss of integrity of tran-
scallosal tracts, most likely attributable to multiple ischemic
insults. Our findings support previous reports which showed
that, in VaD patients, FA diminishes in the anterior part of the
CC.32 We extended these finding by demonstrating a selective
damage of the prefrontal and premotor interhemispheric
tracts. Prefrontal connections play an important role in frontal
network function,3 information processing, set shifting, exec-
utive function, and memory that are often impaired in VaD
patients. It is likely that small white matter lesions in the
frontal lobe cause minor cognitive deficits at the early stages,
but that the presence of rich interhemispheric prefrontal
connections provides access to the contralateral neural sys-
tems that can compensate for the loss of cognitive function.
However, once these interhemispheric connections are se-
verely damaged, this potential no longer exists and clinical
features of dementia on a background of small vessel disease
develop.
Some authors14,33 reported decrease in volume and mean
FA in the anterior part of the CC in VaD. Others found that
the apparent diffusion coefficients are significantly higher in
the anterior portions of CC in VaD compared with healthy
controls and to AD patients.34 High apparent diffusion coef-
ficient values are thought to be associated with axonal
degeneration.35
Quantitative Structural Morphometry
Cortical gray matter in AD (similarly to VaD) was signifi-
cantly diminished when compared with EC. However, white
matter volume in AD was similar to EC and larger than in
VaD. This is consistent with the clinical notion that VaD is
predominantly a subcortical, and AD a cortical, dementia.3
Reduction of cortical mass in VaD is likely to be secondary
to substantial white matter damage through Wallerian
degeneration.
Comparison of CC regions between groups showed a
general trend of reduction of the areas subserving prefrontal
and sensorimotor tracts in AD and VaD. However, the degree
of tissue loss in VaD patients seems to be more pronounced
than in AD. This was particularly evident in the region
including the prefrontal fibers. This finding is supported by
previous studies in which anterior part of the CC was reported
to undergo degenerative process both in AD and VaD.32
Other studies of regional changes in CC have arrived at
varying conclusions. For example, some authors36 identified
significantly smaller posterior midbody, isthmus, and sple-
nium of the corpus callosum compared with controls;
another37 found atrophy of the rostral body and midbody
regions. In our study, the total volume of the CC was not
significantly reduced in VaD patients compared with EC at
a statistical threshold of P0.01. However, volume of PFC
region (and not other CC regions) showed significant
reduction in VaD comparison to AD and controls. These
findings are in contrast with previous studies.38,39 This
discrepancy could be attributable to image analysis tech-
niques used to identify CC regions, registration methods,
inclusion criteria of patients (eg, early vs advanced stage),
and statistical level of significance used. In general, we
found that affine registration is unsuitable for accurate
Figure. Tract-based spatial statistics
analysis and subsequent permutation
analysis showed reduced FA in AD com-
pared to controls (left) and in anterior CC,
frontal, and parietal white matter in VaD
compared to controls. However, when AD
was compared with VaD, the most signifi-
cant area of difference was in the tran-
scallosal prefrontal tracts (P0.0001,
corrected).
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study of the CC. In addition, we aligned all brains and
created CC masks in the midsagittal plane to ensure that
masks were exactly in the same anatomic location. Fur-
thermore, general sparing of the CC volume in our study
can be explained by the fact that our patient groups were at
early stages of their disease, whereas the aforementioned
postmortem studies38 – 40 were performed on advanced
cases.
Discriminating VaD From AD
Discriminant analysis with leave-one-out cross-validation test
showed that mean FA in PFC of CC and Fazekas score
together provided the best discriminator, with overall accu-
racy of 93% and 100% specificity. Reduction of FA values in
premotor cortical region, S1, M1, temporal cortical region,
and parietal cortical region were not associated with volume
reductions in these regions (unlike PFC region). FA volume
dissociation phenomenon is consistent with the notion that
FA changes precede white matter atrophy41 and are therefore
a more sensitive marker for differentiating VaD from AD.
Summary
In this study we showed that tractography-based analysis
combined with tract-based spatial statistics has proved to be
a useful technique to identify specific regional changes in
white matter integrity. Using this approach, we showed that
mean FA in transcallosal prefrontal connections may be a
useful marker to differentiate AD from VaD.
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